APC LIMITED

APC Limited is a global life-science organisation dedicated to accelerating medicine development. Leveraging a robust medicine pipeline, state-of-the-art laboratories and its proprietary AI-driven platform iAchieve®, the company aims to transform how new therapies are discovered and brought to market. The CEO's vision for 2025 includes a €100 million campus expansion that will deepen the firm's deep-tech capabilities and reinforce its commitment to innovative, data-centric drug research.

Through iAchieve®, APC combines artificial intelligence with cutting-edge scientific expertise to streamline candidate selection, optimise clinical pathways and reduce time-to-patient. The firm's worldwide reach enables collaboration with partners across the pharmaceutical ecosystem, offering a clear value proposition for organisations seeking faster, more efficient routes to therapeutic breakthroughs. APC's focus on deep-tech innovation positions it as a forward-looking partner in the evolving landscape of medical research.